OCUP
Ocuphire Pharma, Inc.
Halal Rating :
See Details
Last Price
$1.27
Last updated:
Market Cap
$32.49m
7D Change
3.25%
1 Year Change
-59.94%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 11, 2024
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $1.11m | $9.44m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.71m | $9.42m | - | - | 0.00% | 0.00% |
| Dec. 31, 2023 | $1.69m | $7.12m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Ocuphire Pharma, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.